Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liver

被引:60
|
作者
Wulf, J [1 ]
Hädinger, U [1 ]
Oppitz, U [1 ]
Thiele, W [1 ]
Flentje, M [1 ]
机构
[1] Univ Wurzburg, Dept Radiotherapy, D-97080 Wurzburg, Germany
关键词
stereotactic radiotherapy; stereotactic body frame; conformal radiotherapy; computed tomography simulation; treatment accuracy; dose-volume histogram;
D O I
10.1016/S0167-8140(02)00372-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: Previous analyses of target reproducibility in extracranial stereotactic radiotherapy have revealed standard security margins for planning target volume (PTV) definition of 5 mm in axial and 5-10 mm in longitudinal direction. In this study the reproducibility of the clinical target volume (CTV) of lung and liver tumors within the PTV over the complete course of hypofractionated treatment is evaluated. The impact of target mobility on dose to the CTV is assessed by dose-volume histograms (DVH). Materials and methods: Twenty-two pulmonary and 21 hepatic targets were treated with three stercotactic fractions of 10 Gy to the PTV-enclosing 100%-isodose with normalization to 150% at the isocenter. A conformal dose distribution was related to the PTV, which was defined by margins of 5-10 mm added to the CTV. Prior to each fraction a computed tomography (CT)-simulation over the complete target volume was performed resulting in a total of 60 CT-simulations for lung and 58 CT-simulations for hepatic targets. The CTV from each CT-simulation was segmented and matched with the CT-study used for treatment planning. A DVH of the simulated CTV was calculated for each fraction. The target coverage (TC) of dose to the simulated CTV was defined as the proportion of the CTV receiving at least the reference dose (100%). Results: A decrease of TC to <95% was found in 3/60 simulations (5%) of pulmonary and 7/58 simulations (12%) of hepatic targets. In two of 22 pulmonary targets (9%) and in four of 21 hepatic targets (19%) a TC of <95% occurred in at least one fraction. At risk for a 3 decreased TC <95% were pulmonary targets with increased breathing mobility and hepatic targets with a CTV exceeding 100 cm(3). Conclusions: Target reproducibility was precise within the reference isodose in 91% of lung and 81% of liver tumors with a TC of the complete CTV greater than or equal to95% at each fraction of treatment. Pulmonary targets with increased breathing mobility and liver tumors >100 cm(3) are at risk for target deviation exceeding the standard security margins for PTV-definition at least for one fraction and require individual evaluation of sufficient margins. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 50 条
  • [41] Reirradiation and stereotactic radiotherapy for tumors in the lung: Dose summation and toxicity
    Meijneke, Thomas R.
    Petit, Steven F.
    Wentzler, Davy
    Hoogeman, Mischa
    Nuyttens, Joost J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2013, 107 (03) : 423 - 427
  • [42] Influence of target dose heterogeneity on dose sparing of normal tissue in peripheral lung tumor stereotactic body radiation therapy
    Zhigong Wei
    Xingchen Peng
    Yan Wang
    Lianlian Yang
    Ling He
    Zheran Liu
    Jingjing Wang
    Xiaoli Mu
    Ruidan Li
    Jianghong Xiao
    [J]. Radiation Oncology, 16
  • [43] Influence of target dose heterogeneity on dose sparing of normal tissue in peripheral lung tumor stereotactic body radiation therapy
    Wei, Zhigong
    Peng, Xingchen
    Wang, Yan
    Yang, Lianlian
    He, Ling
    Liu, Zheran
    Wang, Jingjing
    Mu, Xiaoli
    Li, Ruidan
    Xiao, Jianghong
    [J]. RADIATION ONCOLOGY, 2021, 16 (01)
  • [44] Target Delineation, Reposition, and Dose Delivering Accuracies in CBCT-Guided Stereotactic Radiotherapy of Small Lung Tumors
    Li, S.
    Kuritzky, N.
    Chan, P.
    Tsai, J.
    Zhang, X.
    Morgan, P.
    Micaily, B.
    Miyamoto, C.
    [J]. MEDICAL PHYSICS, 2008, 35 (06) : 2948 - +
  • [45] The use of heterogeneity corrections and its impact on delivered dose in patients treated with stereotactic body radiotherapy of the lung
    Rutter, C. E.
    Husain, Z. A.
    Mancini, B. R.
    Naqvi, S. A.
    Zhang, B.
    Marter, K.
    Koshy, M.
    Dhople, A.
    D'Souza, W. D.
    Feigenberg, S. J.
    [J]. JOURNAL OF RADIATION ONCOLOGY, 2014, 3 (01) : 73 - 80
  • [46] Evaluation of Repeated Lung Stereotactic Body Radiotherapy Using a Radiotherapy Dose Accumulation Routine
    Hong, J.
    Yorke, E. D.
    Kuo, L.
    Hu, Y. C.
    Li, X.
    Wu, A. J.
    Liu, Y.
    Mechalakos, J. G.
    Zhang, P.
    Cervino, L. I.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E573 - E573
  • [47] An investigation into the range dependence of target delineation strategies for stereotactic lung radiotherapy
    Mohatt, Dennis J.
    Keim, John M.
    Greene, Mathew C.
    Patel-Yadav, Ami
    Gomez, Jorge A.
    Malhotra, Harish K.
    [J]. RADIATION ONCOLOGY, 2017, 12
  • [48] An investigation into the range dependence of target delineation strategies for stereotactic lung radiotherapy
    Dennis J. Mohatt
    John M. Keim
    Mathew C. Greene
    Ami Patel-Yadav
    Jorge A. Gomez
    Harish K. Malhotra
    [J]. Radiation Oncology, 12
  • [49] Evaluation of the tumor movement and the reproducibility of two different immobilization setups for image-guided stereotactic body radiotherapy of liver tumors
    Dreher, Constantin
    Oechsner, Markus
    Mayinger, Michael
    Beierl, Stefanie
    Duma, Marciana-Nona
    Combs, Stephanie E.
    Habermehl, Daniel
    [J]. RADIATION ONCOLOGY, 2018, 13
  • [50] Evaluation of the tumor movement and the reproducibility of two different immobilization setups for image-guided stereotactic body radiotherapy of liver tumors
    Constantin Dreher
    Markus Oechsner
    Michael Mayinger
    Stefanie Beierl
    Marciana-Nona Duma
    Stephanie E. Combs
    Daniel Habermehl
    [J]. Radiation Oncology, 13